FDA Inspection 1235466 — Mark T. Bloch, MMed, MBBS
The FDA completed an inspection of Mark T. Bloch, MMed, MBBS on Feb 16, 2024 in Darlinghurst. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Darlinghurst (Australia)
Additional Details
Clinical Investigator (CI)